TAF9 and acute myeloid leukemia: PA-treated AML-12 cells exhibited a decrease in TAF9 protein and mRNA expression (Figures 4D,G) accompanied by an significant decrease in fatty acid β-oxidation-related gene protein and mRNA expression (Figures 4E,H) and an increase in LD accumulation-related gene protein and mRNA expression (Figures 4F,I).